Biotech Analysts Kluska and Kim, along with President & CEO Rodriguez of Rigel Pharmaceuticals, President & CEO Sabzevari of Precigen discuss the treatment landscape for acute myeloid Leukemia (relevant companies rigl;pgen;atnm) on an Analyst/Industry conference call to be held on October 26 at 2 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PGEN:
